lonsurf
les laboratoires servier - trifluridine, tipiracil clorhidrat de - neoplasme colorectale - agenți antineoplazici - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.
lonsurf 15 mg/6,14 mg
les laboratoires servier industrie - franta - combinatii (trifluridinum+tipiracilum) - compr. film. - 15 mg/6,14 mg - antimetaboliti analogi ai bazelor pirimidinice
lonsurf 20 mg/8,19 mg
les laboratoires servier industrie - franta - combinatii (trifluridinum+tipiracilum) - compr. film. - 20 mg/8,19 mg - antimetaboliti analogi ai bazelor pirimidinice
solcoseryl 8,3 mg/g gel oftalmic
mylan healthcare sp. z o.o. - combinaţie - gel oftalmic - 8,3 mg/g
relvar ellipta 184 mcg + 22 mcg pulbere unidoză de inhalat
glaxo operation uk limited - fluticasonum + vilanterolum - pulbere unidoză de inhalat - 184 mcg + 22 mcg
relvar ellipta 92 mcg + 22 mcg pulbere unidoză de inhalat
glaxo operation uk limited - fluticasonum + vilanterolum - pulbere unidoză de inhalat - 92 mcg + 22 mcg
avamys spray nazal, suspensie 27,5 mcg/doza
glaxo operation uk limited - spray nazal, suspensie - 27,5 mcg/doza
avamys spray nazal, suspensie 27,5 mcg/doza
glaxo operation uk limited - spray nazal, suspensie - 27,5 mcg/doza
alisade
glaxo group ltd. - furoat de fluticazonă - rhinitis, allergic, perennial; rhinitis, allergic, seasonal - preparate nazale - adulți, adolescenți (între 12 ani și peste) și copii (între 6 și 11 ani). alisade este indicat pentru tratamentul simptomelor de rinită alergică.
avamys
glaxosmithkline (ireland) limited - furoat de fluticazonă - rhinitis, allergic, seasonal; rhinitis, allergic, perennial - nazale preparate, corticosteroizi - adulți, adolescenți (12 ani și peste) și copii (6-11 ani). avamys este indicat pentru tratamentul simptomelor de rinită alergică.